Sjogren’s syndrome in clinical trials of traditional Chinese medicine: protocol for the development of a core outcome set

BACKGROUND: Sjogren’s syndrome (SS) is a chronic autoimmune rheumatic disease with an incidence of 0.03 to 0.3%. In recent years, there are an increasing number of randomized controlled trials of traditional Chinese medicine (TCM) for SS. However, there are generally some problems in these published...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ming, Gao, Ya, Yuan, Yuan, Shi, Shuzhen, Yang, Kelu, Shi, Jiyuan, Wu, Jiarui, Zhang, Junhua, Tian, Jinhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999517/
https://www.ncbi.nlm.nih.gov/pubmed/33771203
http://dx.doi.org/10.1186/s13063-021-05187-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999517/
https://www.ncbi.nlm.nih.gov/pubmed/33771203
http://dx.doi.org/10.1186/s13063-021-05187-8

Ejemplares similares